P1.01-32 A Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients with Interstitial Lung Disease

Authors :: Satoshi Sakaguchi
Hiroshi Nokihara
Takashi Haku
Kenji Otsuka
S. Kakiuchi
Hisatsugu Goto
F. Ogushi
Hiroshi Kawano
Eiji Shimizu
Yasuhiko Nishioka
Yuko Toyoda
Mami Azuma
Masaki Hanibuchi
Shinji Atagi
Mayo Kondo
Source :: Journal of Thoracic Oncology. 13:S472
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Interstitial lung disease
medicine.disease
Carboplatin
chemistry.chemical_compound
chemistry
Internal medicine
medicine
Non small cell
Open label
Lung cancer
business

Tools